APM Stock Analysis: Buy, Sell, or Hold?
APM - Aptorum Group Limited Class A Ordinary Shares
$0.70
0.01 (1.10%)
▲
5d:
-10.49%
30d:
-16.92%
90d:
-22.22%
WAIT
LOW Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Jun 26, 2026
0d
Get Alerted When APM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: APM is down 10.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: APM is down 10.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: APM is currently trading at $0.70, which is considered fair based on recent price action.
Technical Outlook: Technically, APM is in a uptrend. Immediate support is located at $0.60, while resistance sits at $0.83.
Market Sentiment: APM scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $80.00 (+11328.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APM is in a uptrend. Immediate support is located at $0.60, while resistance sits at $0.83.
Market Sentiment: APM scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $80.00 (+11328.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
46/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Trading 11328.6% below Wall St target ($80.00)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Support & Resistance Levels
Support Level
$0.60
Resistance Level
$0.83
Current Trend
Uptrend
Technical data as of
Jul 17, 2026
Fundamental Context
Wall Street Target
$80.00
(+11328.6%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: October 05, 2026 2:32 PM ET
Data refreshes hourly during market hours. Next update: 3:32 PM
Data refreshes hourly during market hours. Next update: 3:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$571 | 51 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
20 analysts |
$307 | 68 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
29 analysts |
$371 | 41 HOLD |
|
STOK
Stoke Therapeutics Inc |
STRONG BUY
14 analysts |
$46 | 67 BUY |
|
KURA
Kura Oncology Inc |
STRONG BUY
16 analysts |
$32 | 62 BUY |
